Refine
Has Fulltext
- yes (22)
Is part of the Bibliography
- yes (22)
Year of publication
Document Type
- Journal article (22)
Language
- English (22)
Keywords
- neutrino astronomy (2)
- ANTARES telescope (1)
- Accidental coincidence (1)
- African-americans (1)
- Atmospheric muons (1)
- Biochemie (1)
- CVID (1)
- Cerebral-ischemia (1)
- Chronic Kidney-disease (1)
- Copy number changes (1)
- DNA methylferase homolog (1)
- Diabetic-nephropathy (1)
- European Society for Immunodeficiencies (ESID) (1)
- Galactic Ridge (1)
- Gamma-ray bursts (1)
- General-population (1)
- German PID-NET registry (1)
- Glomerular-filtration-rate (1)
- Head-injury (1)
- Hemodynamic depression (1)
- IgG substitution therapy (1)
- Intravascular coagulation (1)
- Jaynes-Cummings ladder (1)
- Medizin (1)
- Mice (1)
- Model (1)
- Molecular-weight heparin (1)
- Mortality (1)
- Neutrino data (1)
- Neutrino emission (1)
- Neutrino telescope (1)
- PID prevalence (1)
- Progression (1)
- Rats (1)
- Risk (1)
- Search window (1)
- Stage renal-disease (1)
- Survival (1)
- TRNA(ASP) (1)
- Thrombus formation (1)
- Variants (1)
- WIMP (1)
- amyotrophic lateral sclerosis (1)
- association (1)
- beaver-dam eye (1)
- binding (1)
- bone morphogenetic proteins (1)
- cardiac arrest documentation (1)
- cardiopulmonary resuscitation (1)
- cartilage induction (1)
- central corneal thickness (1)
- coherence (1)
- congenital myopathy (1)
- dark matter (1)
- dark matter detectors (1)
- dark matter experiments (1)
- deep sea neutrino telescope (1)
- dot (1)
- drospophila (1)
- epigenetics in the nervous system (1)
- epigenomics (1)
- eutrino physics (1)
- expression (1)
- filamin C (1)
- fragmentation functions (1)
- gain (1)
- gene expression (1)
- genome-wide association studies (1)
- genome-wide scan (1)
- goldmann applanation tonometer (1)
- identification (1)
- in-vivo (1)
- indirect detection (1)
- jet shapes (1)
- jets (1)
- light (1)
- mechanism (1)
- microcavity (1)
- myofibrillar myopathy (1)
- nanographene (1)
- neurological disorders (1)
- neutralino (1)
- neutralizing antibodies (1)
- neutrino detectors (1)
- neutrino emission (1)
- neutrino mass hierarchy (1)
- neutrino telescope (1)
- no-flow fraction (1)
- non-fullerene acceptors (1)
- onset (1)
- organic solar cells (1)
- oscillations (1)
- photon (1)
- polycyclic aromatic hydrocarbons (1)
- population (1)
- primary immunodeficiency (PID) (1)
- proteomic signature (1)
- psychiatry (1)
- recessive inheritance (1)
- registry for primary immunodeficiency (1)
- resonance (1)
- self-assembly (1)
- semiconductor lasers (1)
- simulation (1)
- spectral interferometry (1)
- spectroscopy (1)
- sun (1)
- system (1)
- to-disc ratio (1)
Institute
- Institut für Theoretische Physik und Astrophysik (6)
- Physikalisches Institut (3)
- Medizinische Klinik und Poliklinik II (2)
- Augenklinik und Poliklinik (1)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut Mensch - Computer - Medien (1)
- Institut für Humangenetik (1)
- Institut für Klinische Neurobiologie (1)
- Institut für Medizinische Strahlenkunde und Zellforschung (1)
- Institut für Molekulare Infektionsbiologie (1)
A series of novel imide‐functionalized C\(_{64}\) nanographenes is investigated as acceptor components in organic solar cells (OSCs) in combination with donor polymer PM6. These electron‐poor molecules either prevail as a monomer or self‐assemble into dimers in the OSC active layer depending on the chosen imide substituents. This allows for the controlled stacking of electron‐poor and electron‐rich π–scaffolds to establish a novel class of non‐fullerene acceptor materials to tailor the bulk‐heterojunction morphology of the OSCs. The best performance is observed for derivatives that are able to self‐assemble into dimers, reaching power conversion efficiencies of up to 7.1%.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects 1 in ~350 individuals. Genetic association studies have established ALS as a multifactorial disease with heritability estimated at ~61%, and recent studies show a prominent role for rare variation in its genetic architecture. To identify rare variants associated with disease onset we performed exome array genotyping in 4,244 cases and 3,106 controls from European cohorts. In this largest exome-wide study of rare variants in ALS to date, we performed single-variant association testing, gene-based burden, and exome-wide individual set-unique burden (ISUB) testing to identify single or aggregated rare variation that modifies disease risk. In single-variant testing no variants reached exome-wide significance, likely due to limited statistical power. Gene-based burden testing of rare non-synonymous and loss-of-function variants showed NEK1 as the top associated gene. ISUB analysis did not show an increased exome-wide burden of deleterious variants in patients, possibly suggesting a more region-specific role for rare variation. Complete summary statistics are released publicly. This study did not implicate new risk loci, emphasizing the immediate need for future large-scale collaborations in ALS that will expand available sample sizes, increase genome coverage, and improve our ability to detect rare variants associated to ALS.